Utility of Casual Postprandial Glucose Levels in Type 2 Diabetes Management
Open Access
- 1 February 2004
- journal article
- conference paper
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (2) , 335-339
- https://doi.org/10.2337/diacare.27.2.335
Abstract
OBJECTIVE—Because readily available glycemic indicators are needed to guide clinical decision-making for intensification of diabetes therapy, our goals were to define the relationship between casual postprandial plasma glucose (cPPG) levels and HbA1c in patients with type 2 diabetes and to determine the predictive characteristics of a convenient glucose cutoff. RESEARCH DESIGN AND METHODS—We examined the relationship between cPPG levels (1–4 h post meal) and HbA1c levels in 1,827 unique patients who had both determinations during a single office visit. RESULTS—The population studied was predominantly African American and middle-aged, with average cPPG of 201 mg/dl and HbA1c of 8.4%. The prevalence of HbA1c ≥7.0% was 67% and HbA1c >6.5% was 77%. Overall, cPPG and HbA1c were linearly correlated (r = 0.63, P < 0.001). The correlation between cPPG and HbA1c was strongest in patients treated with diet alone (n = 348, r = 0.75, P < 0.001) and weaker but still highly significant for patients treated with oral agents (n = 610, r = 0.64, P < 0.001) or insulin (n = 869, r = 0.56, P < 0.001). A cutoff cPPG >150 mg/dl predicted an HbA1c level ≥7.0% in the whole group, with a sensitivity of 78%, a specificity of 62%, and an 80% positive predictive value. The same cPPG cutoff of 150 mg/dl predicted an HbA1c level >6.5%, with a sensitivity of 74%, a specificity of 66%, and an 88% positive predictive value. CONCLUSIONS—When rapid-turnaround HbA1c determinations are not available, a single cPPG level >150 mg/dl may be used during a clinic visit to identify most inadequately controlled patients and allow timely intensification of therapy.This publication has 35 references indexed in Scilit:
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2003
- Diabetes in urban African-Americans. XVI. Overcoming clinical inertia improves glycemic control in patients with type 2 diabetes.Diabetes Care, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Is the Quality of Diabetes Care Better in a Diabetes Clinic or in a General Medicine Clinic?Diabetes Care, 1997
- Ambulatory Medical Care for Non-Hispanic Whites, African-Americans, and Mexican-Americans With NIDDM in the U.SDiabetes Care, 1997
- Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experienceDiabetes Care, 1996
- NIDDM and its metabolic control predict coronary heart disease in elderly subjectsDiabetes, 1994
- Optimizing Blood Glucose Control in Type 2 Diabetes: an Approach Based on Fasting Blood Glucose MeasurementsDiabetic Medicine, 1988
- comparative Clinical Reliability of Fasting Plasma Glucose and Glycosylated Hemoglobin in Non-Insulin-Dependent Diabetes MellitusDiabetes Care, 1986
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984